✦ LIBER ✦

Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)

✍ Scribed by Probal Roy; Laurent Bonello; Axel de Labriolle; Teruo Okabe; Tina L. Pinto Slottow; Daniel H. Steinberg; Rebecca Torguson; Kimberly Smith; Zhenyi Xue; Lowell F. Satler; Kenneth M. Kent; William O. Suddath; Augusto D. Pichard; Ron Waksman

Book ID: 113444864
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 409 KB
Volume: 102
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2008.03.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-Year Outcomes Following Sirolimus-

Three-Year Outcomes Following Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)

✍ Nicholas N. Hanna; Michael A. Gaglia Jr.; Rebecca Torguson; Itsik Ben-Dor; Manue 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Three-year outcomes following sirolimus-

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease: The REWARDS Registry

✍ Nicholas Hanna; Michael A. Gaglia Jr; Rebecca Torguson; Itsik Ben-Dor; Sara D. C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Sirolimus- versus paclitaxel-eluting ste

Sirolimus- versus paclitaxel-eluting stent experience in an unselected population with coronary artery disease (C- versus T-REWARD registries)

✍ A.N. Buch; R. Waksman; P.K. Kuchulakanti; W.W. Chu; A. Javaid; R. Torguson; K. S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-Term Clinical Outcomes and Thrombos

Long-Term Clinical Outcomes and Thrombosis Rates of Sirolimus-Eluting Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (REWARDS Registry)

✍ Ron Waksman; Ashesh N. Buch; Rebecca Torguson; Zhenyi Xue; Kimberly Smith; Aamir 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Sirolimus-Eluting Stents Versus Paclitax

Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes Mellitus

✍ Pramod K. Kuchulakanti; William W. Chu; Rebecca Torguson; Leonardo Clavijo; Rosw 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Cost Analysis From Two Randomized Trials

Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease

✍ Shpend Elezi; Alban Dibra; Ulrike Folkerts; Julinda Mehilli; Sylvia Heigl; Alber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 359 KB